The Russian Expert Council on the application of new highly selective inhibitor of Bruton’s tyrosine kinase zanubrutinib in the treatment of patients with relapsed/refractory mantle cell lymphoma. Event review
Keyword(s):
The meeting of the expert council concerning the application of new highly selective inhibitor of Brutons tyrosine kinase zanubrutinib in the treatment of patients with relapsed/refractory mantle cell lymphoma was held in Moscow on April 21, 2021. The leading Russian experts in the field of oncohematology took part in the meeting.
2020 ◽
Vol 26
(16)
◽
pp. 4216-4224
◽
2020 ◽
Vol 26
(5)
◽
pp. 1190-1199
2018 ◽
pp. molcanther.0478.2018
◽
2012 ◽
Keyword(s):
2017 ◽
Vol 142
(1)
◽
pp. 202-213
◽
2019 ◽
pp. molcanres.0256.2018
◽